CLVG The Skinny on GLP-1s

“ One of the things I think is going to be really interesting about this impact on our industry is that many times outside influences, specifically in buying habits, tend to be very trendy...One of the really big motivators in using these GLP-1 drugs is the goal of people wanting to lose weight and for them to feel better about themselves, theoretically, without having to do any work. It’s the ideal way of people trying to lose weight and to become the people that they want to become. It’s the motivation and the motivating factor that I think is maybe much more enduring than what we’ve seen in the past. Roy Strasburger , CEO, StrasGlobal, President, Compliance Safe, Vision Group Network Co-Founder “ Remember there are so many people that are scared of the GLP-1s. They’re nervous about hearing that people rebound and gain their weight back. They’re nervous about the side effects and the cost is high. So there’s an addressable market of people that are interested in a GLP-1 but not going to go on it. Sherry Frey , Vice President of Total Wellness, Nielsen IQ

NOTABLE AND QUOTABLE

“ There could be two or three other people in those households that are listening to the new habits of the user and transferring those habits to themselves, possibly—eating higher protein, eating less sweets, more hydration. Hal Adams , Senior Advisor, U.S. Proximity FEMSA/OXXO

“

My hunch at the moment

is that the usage of these drugs is still underrepresented in our customer audience where we cater towards the more blue collar, less health conscious consumer because we’re selling a lot of beer and cigarettes, right? But as this starts moving down and becoming cheaper, it’s for sure going to be a trend to watch. Joris van Brussel , CEO Shell Mobility and Convenience, Shell USA

“ One thing I would say, and probably most of you are doing this, is really looking at data for your market. The markets that your stores are in, in terms of GLP-1 prescriptions. There are markets in this country that are much heavier in terms of penetration of prescriptions. Sherry Frey , Vice President of Total Wellness, Nielsen IQ

“ There’s going to be a huge opportunity for the retailers who are prepared and are being innovative to differentiate themselves from other people in the industry and to take advantage of what these new opportunities are going to be. Greg Parker , Executive Chairman , Parker’s

“ I agree with people who say this could be the biggest lifestyle disruptor in our lifetime because of the effect it’s having on relationships between people who are choosing to go on GLP-1s. Eva Strasburger , President, StrasGlobal, CEO, Compliance Safe, Vision Group Network Co-Founder